Perspective Therapeutics

Forecast & Rating16 analysts currently cover Perspective Therapeutics, with about 93.8% giving a positive rating — meaning they expect the stock to rise. The average price target is $12.53, about 303.0% upside from the current price of $3.11. Price targets range from $5.00 to $18.00 — a wide spread, showing clear disagreement over just how much Perspective Therapeutics can rise. Historically, about 45.3% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Perspective Therapeutics closely still see room for the stock to rise. Data as of Aug 20, 2026; for reference only and not investment advice.